Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
1 "Persistent lymphedema"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Article
Identification of Prognostic Risk Factors for Transient and Persistent Lymphedema after Multimodal Treatment for Breast Cancer
Myungsoo Kim, Kyung Hwan Shin, So-Youn Jung, Seeyoun Lee, Han-Sung Kang, Eun Sook Lee, Seung Hyun Chung, Yeon-Joo Kim, Tae Hyun Kim, Kwan Ho Cho
Cancer Res Treat. 2016;48(4):1330-1337.   Published online February 3, 2016
DOI: https://doi.org/10.4143/crt.2015.463
AbstractAbstract PDFPubReaderePub
Purpose
The purpose of this study is to identify risk factors for transient lymphedema (TLE) and persistent lymphedema (PLE) following treatment for breast cancer. Materials and Methods A total of 1,073 patients who underwent curative breast surgery were analyzed. TLE was defined as one episode of arm swelling that had resolved spontaneously by the next followup; arm swelling that persisted over two consecutive examinations was considered PLE.
Results
At a median follow-up period of 5.1 years, 370 cases of lymphedema were reported, including 120 TLE (11.2%) and 250 PLE (23.3%). Initial grade 1 swelling was observed in 351 patients, of which 120 were limited to TLE (34%), while the other 231 progressed to PLE (66%). All initial swelling observed in TLE patients was classified as grade 1. In multivariate analysis, chemotherapy with taxane and supraclavicular radiation therapy (SCRT) were associated with development of TLE, whereas SCRT, stage III cancer and chemotherapy with taxane were identified as risk factors for PLE (p < 0.05). The estimated incidence of TLE among initial grade 1 patients was calculated using up to three treatment-related risk factors (number of dissected axillary lymph nodes, SCRT, and taxane chemotherapy). The approximate ratios of TLE and PLE based on the number of risk factors were 7:1 (no factor), 1:1 (one factor), 1:2 (two factors), and 1:3 (three factors). Conclusion One-third of initial swelling events were transient, whereas the other two-thirds of patients experienced PLE. Estimation of TLE and PLE based on known treatment factors could facilitate prediction of this life-long complication.

Citations

Citations to this article as recorded by  
  • Efficacy of preoperative lymphoscintigraphy in predicting surgical outcomes of lymphaticovenous anastomosis in lower extremity lymphedema: Clinical correlations in gynecological cancer-related lymphedema
    Min Young Yoo, Kyong-Je Woo, Seo Young Kang, Byung Seok Moon, Bom Sahn Kim, Hai-Jeon Yoon, Andrea Giannini
    PLOS ONE.2024; 19(1): e0296466.     CrossRef
  • Lymphatic remapping by long-term lymphoscintigraphy follow-up in secondary lymphedema after breast cancer surgery
    Garam Hong, Koeun Lee, Sangwon Han, Jae Yong Jeon
    Scientific Reports.2024;[Epub]     CrossRef
  • The effect of exercise and educational programs for breast cancer patients on the development of breast cancer-related lymphoedema: secondary endpoint from a randomized controlled trial in the Setouchi Breast Project-10
    Shogo Nakamoto, Takayuki Iwamoto, Naruto Taira, Yukiko Kajiwara, Kengo Kawada, Daisuke Takabatake, Yuichiro Miyoshi, Shinichiro Kubo, Yoko Suzuki, Mari Yamamoto, Yutaka Ogasawara, Minami Hatono, Seiji Yoshitomi, Kyoko Hara, Asako Sasahara, Shozo Ohsumi, M
    Breast Cancer.2024; 31(5): 969.     CrossRef
  • The prevalence of arm lymphedema after radiation treatment in patients with breast cancer
    Kamonrat Sueangamiam, Kanisa Rongsriyam
    Journal of Radiotherapy in Practice.2023;[Epub]     CrossRef
  • The Use of Ultrasound Imaging for Upper Extremity Lymphedema after Breast Cancer: A Systematic Review
    Elena Canales-Lachén, Ángel Asunsolo, Oscar J. Manrique, Javier Blázquez, Purificación Holguín, Andrés A. Maldonado
    Journal of Reconstructive Microsurgery.2023; 39(02): 102.     CrossRef
  • Risk factors of unilateral breast cancer-related lymphedema: an updated systematic review and meta-analysis of 84 cohort studies
    Aomei Shen, Qian Lu, Xin Fu, Xiaoxia Wei, Liyuan Zhang, Jingru Bian, Wanmin Qiang, Dong Pang
    Supportive Care in Cancer.2023;[Epub]     CrossRef
  • Risk factors for the development of severe breast cancer-related lymphedema: a retrospective cohort study
    Xiaozhen Liu, Kewang Sun, Hongjian Yang, Lingli Xia, Kefeng Lu, Xuli Meng, Yongfeng Li
    BMC Cancer.2023;[Epub]     CrossRef
  • Practical Approach to Establishing a Lymphedema Screening Program: Tips and Tricks
    Derly C. Munoz, Sarah S. Virk, Oluwadamilola T. Oladeru, Pamela Clevenger, Tracy L. Hollen, Mariam W. Hanna, Lisa R. P. Spiguel
    Current Breast Cancer Reports.2023; 15(3): 242.     CrossRef
  • The impact of rehabilitation sport on breast cancer-related lymphoedema and quality of life
    Bettina Boeer, Anna Seller, Birgitt Schoenfisch, Ute krainick-Strobel, Andreas Dietrich, Sara Y. Brucker, Diethelm Wallwiener, Andreas Niess, Markus Hahn
    Archives of Gynecology and Obstetrics.2022; 307(5): 1529.     CrossRef
  • The potential of gas plasma technology for targeting breast cancer
    Sander Bekeschus, Fariba Saadati, Steffen Emmert
    Clinical and Translational Medicine.2022;[Epub]     CrossRef
  • Prediction of breast cancer-related lymphedema risk after postoperative radiotherapy via multivariable logistic regression analysis
    Jae Sik Kim, Jin Ho Kim, Ji Hyun Chang, Do Wook Kim, Kyung Hwan Shin
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Invited Commentary from the Authors of: Kuruvilla AS, et al. Risk Factors Associated With Postmastectomy Breast Cancer Lymphedema: Amulticenter Retrospective Analysis
    Annet S. Kuruvilla
    Annals of Plastic Surgery.2022; 89(6): 716.     CrossRef
  • Development and validation of a nomogram to predict the risk of breast cancer-related lymphedema among Chinese breast cancer survivors
    Yan-fei Liu, Jun-E Liu, Yi Zhu, Yim Wah Mak, Hui Qiu, Li-hui Liu, Shen-shen Yang, Shao-hua Chen
    Supportive Care in Cancer.2021; 29(9): 5435.     CrossRef
  • Eliminating the Burden of Lymphedema in Cancer Patients Requiring Nodal Dissections Using Prophylactic Immediate Lymphatic Reconstruction – A Case Report and Review of the Literature
    Abiye Mussie, Maria C. Medor, Sylia Mohand-Said, Andrea M. Ibrahim, Carolyn Nessim, Moein Momtazi
    Plastic Surgery Case Studies.2021;[Epub]     CrossRef
  • Factors predicting one or two sentinel lymph nodes to be accepted for sentinel lymph node biopsy alone after neoadjuvant therapy in initially node-positive breast cancer patients
    Li-Wei Tsai, Yi-Hsuan Lee, Chiao Lo, Huang-Chun Lien, Ming-Yang Wang, I-Shiow Jan, Ruoh-Fang Yen, Fu-Chang Hu, Chiun-Sheng Huang
    Surgical Oncology.2021; 39: 101667.     CrossRef
  • Sentinel Lymph Node Biopsy in T3 and T4b Breast Cancer Patients: Analysis in a Tertiary Cancer Hospital and Systematic Literature Review
    Idam de Oliveira-Junior, Eliana Aguiar Petri Nahas, Ana Cristina Cherem, Jorge Nahas-Neto, René Aloisio da Costa Vieira
    Breast Care.2021; 16(1): 27.     CrossRef
  • Histological features of skin and subcutaneous tissue in patients with breast cancer who have received neoadjuvant chemotherapy and their relationship to post-treatment edema
    Ayako Nakagawa, Hiroshi Fujimoto, Takeshi Nagashima, Takafumi Sangai, Mamoru Takada, Takahito Masuda, Ryotaro Teranaka, Satoshi Ota, Jun Matsushima, Shinsuke Akita, Masayuki Ohtsuka
    Breast Cancer.2020; 27(1): 77.     CrossRef
  • Lymphedema Signs, Symptoms, and Diagnosis in Women Who Are in Minority and Low-Income Groups and Have Survived Breast Cancer
    Ann Marie Flores, Jason Nelson, Lee Sowles, Rebecca G Stephenson, Kathryn Robinson, Andrea Cheville, Antoinette P Sander, William J Blot
    Physical Therapy.2020; 100(3): 487.     CrossRef
  • Prevalence of obstructive sleep apnea syndrome in patients with lymphedema referred for complete decongestive therapy
    Côme Roux, Béatrice Villemur, Brigitte Giovannoni, Lucie Koeyemelk, Monique Mendelson, Meriem Benmerad, Marie Joyeux-Faure, Renaud Tamisier, Jean-Louis Pepin
    Journal of Vascular Surgery: Venous and Lymphatic Disorders.2020; 8(1): 137.     CrossRef
  • The results of the intensive phase of complete decongestive therapy and the determination of predictive factors for response to treatment in patients with breast cancer related‐lymphedema
    Dilek Keskin, Meltem Dalyan, Sibel Ünsal‐Delialioğlu, Ülkü Düzlü‐Öztürk
    Cancer Reports.2020;[Epub]     CrossRef
  • A scoring system for predicting the risk of breast cancer-related lymphedema
    Fenglian Li, Qian Lu, Sanli Jin, Quanping Zhao, Xueying Qin, Shuai Jin, Lichuan Zhang
    International Journal of Nursing Sciences.2020; 7(1): 21.     CrossRef
  • Lymphedema and Lymphovenous Bypass: Perioperative Nursing Implications
    Lori A. Whitnell
    AORN Journal.2020; 111(2): 187.     CrossRef
  • Who Will Continuously Depend on Compression to Control Persistent or Progressive Breast Cancer-Related Lymphedema Despite 2 Years of Conservative Care?
    Chul Jung, JaYoung Kim, Yu Jin Seo, Kyeong Joo Song, Ma. Nessa Gelvosa, Jin Geun Kwon, Changsik John Pak, Hyunsuk Peter Suh, Joon Pio Hong, Hwa Jung Kim, Jae Yong Jeon
    Journal of Clinical Medicine.2020; 9(11): 3640.     CrossRef
  • Role of p53 as a prognostic marker in breast carcinoma and its correlation with tumor size, tumor grade and lymph node metastasis
    Alok Mohan, Bharat Jindal, Rajender Kumar Thakral, Vaseem Ansari, Veena K Sharma
    Indian Journal of Pathology and Oncology.2020; 7(3): 378.     CrossRef
  • Risk factors and prediction model for persistent breast-cancer-related lymphedema: a 5-year cohort study
    I-Wen Penn, Yue-Cune Chang, Eric Chuang, Chi-Ming Chen, Chi-Feng Chung, Chia-Yu Kuo, Tien-Yow Chuang
    Supportive Care in Cancer.2019; 27(3): 991.     CrossRef
  • Progressive resistance training to prevent arm lymphedema in the first year after breast cancer surgery: Results of a randomized controlled trial
    Gunn Ammitzbøll, Christoffer Johansen, Charlotte Lanng, Elisabeth Wreford Andersen, Niels Kroman, Bo Zerahn, Ole Hyldegaard, Merete Celano Wittenkamp, Susanne Oksbjerg Dalton
    Cancer.2019; 125(10): 1683.     CrossRef
  • Frequency and risk factors for arm lymphedema after multimodal breast-conserving treatment of nodal positive breast Cancer – a long-term observation
    Julia Rupp, Catarina Hadamitzky, Christoph Henkenberens, Hans Christiansen, Diana Steinmann, Frank Bruns
    Radiation Oncology.2019;[Epub]     CrossRef
  • Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis
    Fabiola Giudici, Elisabetta Petracci, Oriana Nanni, Cristina Bottin, Maurizio Pinamonti, Fabrizio Zanconati, Bruna Scaggiante, Aamir Ahmad
    PLOS ONE.2019; 14(6): e0218030.     CrossRef
  • Introduction of the Lymphedema Action Plan (LeAP): Clinical Advancement in Proactive Lymphedema Care
    Renata Beaman
    Rehabilitation Oncology.2019; 37(3): 122.     CrossRef
  • Profile of women with lymphedema after breast cancer treatment
    Thais de Oliveira Gozzo, Gabriela Aguado, Aniele Tomadon, Marislei Sanches Panobianco, Maria Antonieta Spinoso Prado
    Escola Anna Nery.2019;[Epub]     CrossRef
  • Lymphatic Microsurgical Preventing Healing Approach (LYMPHA) for Prevention of Breast Cancer-Related Lymphedema—a Preliminary Report
    Juhi Agrawal, Sandeep Mehta, Ashish Goel, Pankaj Kumar Pande, Kapil Kumar
    Indian Journal of Surgical Oncology.2018; 9(3): 369.     CrossRef
  • Progressive strength training to prevent LYmphoedema in the first year after breast CAncer – the LYCA feasibility study
    Gunn Ammitzbøll, Charlotte Lanng, Niels Kroman, Bo Zerahn, Ole Hyldegaard, Klaus Kaae Andersen, Christoffer Johansen, Susanne Oksbjerg Dalton
    Acta Oncologica.2017; 56(2): 360.     CrossRef
  • Association between adjuvant docetaxel-based chemotherapy and breast cancer-related lymphedema
    Wen Zhu, Dan Li, Xiaoqin Li, Jin Ren, Wenqi Chen, Hangang Gu, Yongqian Shu, Deqiang Wang
    Anti-Cancer Drugs.2017; 28(3): 350.     CrossRef
  • P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients
    Yunbao Pan, Yufen Yuan, Guoshi Liu, Yongchang Wei, William B. Coleman
    PLOS ONE.2017; 12(2): e0172324.     CrossRef
  • Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema: Recommendations from a Multidisciplinary Expert ASBrS Panel
    Sarah A. McLaughlin, Alicia C. Staley, Frank Vicini, Paul Thiruchelvam, Nancy A. Hutchison, Jane Mendez, Fiona MacNeill, Stanley G. Rockson, Sarah M. DeSnyder, Suzanne Klimberg, Michael Alatriste, Francesco Boccardo, Mark L. Smith, Sheldon M. Feldman
    Annals of Surgical Oncology.2017; 24(10): 2818.     CrossRef
  • Current and future perspectives on the evaluation, prevention and conservative management of breast cancer related lymphoedema: A best practice guideline
    Nick Gebruers, Hanne Verbelen, Tessa De Vrieze, Lore Vos, Nele Devoogdt, Lore Fias, Wiebren Tjalma
    European Journal of Obstetrics & Gynecology and Reproductive Biology.2017; 216: 245.     CrossRef
  • Changes in volume and incidence of lymphedema during and after treatment with docetaxel, doxorubicin, and cyclophosphamide (TAC) in patients with breast cancer
    Janine T. Hidding, Carien H. G. Beurskens, Philip J. van der Wees, Wilmy C. A. M. Bos, Maria W. G. Nijhuis-van der Sanden, Hanneke W. M. van Laarhoven
    Supportive Care in Cancer.2017;[Epub]     CrossRef
  • Palliative surgery for giant mucinous carcinoma of the breast in an elderly patient: A rare case report
    Haruko Takuwa, Wakako Tsuji, Fumiaki Yotsumoto
    Molecular and Clinical Oncology.2017; 7(4): 609.     CrossRef
  • Update December 2016
    Francine Blei
    Lymphatic Research and Biology.2016; 14(4): 240.     CrossRef
  • 12,468 View
  • 241 Download
  • 43 Web of Science
  • 39 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP